estriol has been researched along with Bronchopulmonary Dysplasia in 1 studies
hormonin: estrogen replacement; each tablet contains 600 ug micronized 17beta-estradiol, 270 ug estriol and 1.4 mg estrone
chlorapatite : A phosphate mineral with the formula Ca5(PO4)3Cl.
Bronchopulmonary Dysplasia: A chronic lung disease developed after OXYGEN INHALATION THERAPY or mechanical ventilation (VENTILATION, MECHANICAL) usually occurring in certain premature infants (INFANT, PREMATURE) or newborn infants with respiratory distress syndrome (RESPIRATORY DISTRESS SYNDROME, NEWBORN). Histologically, it is characterized by the unusual abnormalities of the bronchioles, such as METAPLASIA, decrease in alveolar number, and formation of CYSTS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Although maternal serum α-fetoprotein (AFP), human chorionic gonandotropin (hCG), and estriol play important roles in immunomodulation and immunoregulation during pregnancy, their relationship with the development of bronchopulmonary dysplasia (BPD) in young infants is unknown despite BPD being associated with pre- and postnatal inflammatory factors." | 7.78 | Risk of bronchopulmonary dysplasia by second-trimester maternal serum levels of α-fetoprotein, human chorionic gonadotropin, and unconjugated estriol. ( Baer, RJ; Currier, RJ; Gould, JB; Jelliffe-Pawlowski, LL; O'Brodovich, HM; Oehlert, JW; Quaintance, C; Santos, AJ; Shaw, GM; Stevenson, DK, 2012) |
| "Although maternal serum α-fetoprotein (AFP), human chorionic gonandotropin (hCG), and estriol play important roles in immunomodulation and immunoregulation during pregnancy, their relationship with the development of bronchopulmonary dysplasia (BPD) in young infants is unknown despite BPD being associated with pre- and postnatal inflammatory factors." | 3.78 | Risk of bronchopulmonary dysplasia by second-trimester maternal serum levels of α-fetoprotein, human chorionic gonadotropin, and unconjugated estriol. ( Baer, RJ; Currier, RJ; Gould, JB; Jelliffe-Pawlowski, LL; O'Brodovich, HM; Oehlert, JW; Quaintance, C; Santos, AJ; Shaw, GM; Stevenson, DK, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jelliffe-Pawlowski, LL | 1 |
| Shaw, GM | 1 |
| Stevenson, DK | 1 |
| Oehlert, JW | 1 |
| Quaintance, C | 1 |
| Santos, AJ | 1 |
| Baer, RJ | 1 |
| Currier, RJ | 1 |
| O'Brodovich, HM | 1 |
| Gould, JB | 1 |
1 other study available for estriol and Bronchopulmonary Dysplasia
| Article | Year |
|---|---|
Risk of bronchopulmonary dysplasia by second-trimester maternal serum levels of α-fetoprotein, human chorionic gonadotropin, and unconjugated estriol.
Topics: Adolescent; Adult; alpha-Fetoproteins; Biomarkers; Bronchopulmonary Dysplasia; Chorionic Gonadotropi | 2012 |